[CIMB] QoQ TTM Result on 30-Sep-2020 [#3]

Announcement Date
27-Nov-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Sep-2020 [#3]
Profit Trend
QoQ- -30.86%
YoY- -62.14%
View:
Show?
TTM Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 19,807,946 19,002,639 17,189,003 16,995,402 17,169,233 17,772,762 17,795,879 7.40%
PBT 5,095,415 3,714,104 1,530,329 2,443,349 3,326,234 5,085,678 5,974,840 -10.07%
Tax -1,134,409 -591,402 -383,760 -726,483 -802,108 -1,339,421 -1,519,653 -17.72%
NP 3,961,006 3,122,702 1,146,569 1,716,866 2,524,126 3,746,257 4,455,187 -7.54%
-
NP to SH 3,950,836 3,143,732 1,194,424 1,828,089 2,643,993 3,875,539 4,559,656 -9.12%
-
Tax Rate 22.26% 15.92% 25.08% 29.73% 24.11% 26.34% 25.43% -
Total Cost 15,846,940 15,879,937 16,042,434 15,278,536 14,645,107 14,026,505 13,340,692 12.17%
-
Net Worth 58,381,023 57,370,620 55,925,837 55,071,469 56,061,782 54,696,383 55,791,709 3.07%
Dividend
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Div 1,520,473 477,294 477,294 1,181,318 1,181,318 2,537,140 2,537,140 -28.94%
Div Payout % 38.48% 15.18% 39.96% 64.62% 44.68% 65.47% 55.64% -
Equity
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Net Worth 58,381,023 57,370,620 55,925,837 55,071,469 56,061,782 54,696,383 55,791,709 3.07%
NOSH 10,014,189 9,922,971 9,922,971 9,922,971 9,922,971 9,922,971 9,922,971 0.61%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 20.00% 16.43% 6.67% 10.10% 14.70% 21.08% 25.03% -
ROE 6.77% 5.48% 2.14% 3.32% 4.72% 7.09% 8.17% -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 198.24 191.50 173.22 171.27 173.03 179.11 180.77 6.34%
EPS 39.54 31.68 12.04 18.42 26.65 39.06 46.32 -10.02%
DPS 15.25 4.81 4.81 12.00 12.00 25.57 25.77 -29.53%
NAPS 5.8427 5.7816 5.636 5.5499 5.6497 5.5121 5.6674 2.05%
Adjusted Per Share Value based on latest NOSH - 9,922,971
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 184.78 177.27 160.35 158.55 160.17 165.80 166.01 7.40%
EPS 36.86 29.33 11.14 17.05 24.67 36.15 42.54 -9.12%
DPS 14.18 4.45 4.45 11.02 11.02 23.67 23.67 -28.95%
NAPS 5.4462 5.3519 5.2172 5.1375 5.2298 5.1025 5.2046 3.07%
Price Multiplier on Financial Quarter End Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 -
Price 4.61 4.34 4.30 3.08 3.56 3.60 5.15 -
P/RPS 2.33 2.27 2.48 1.80 2.06 2.01 2.85 -12.57%
P/EPS 11.66 13.70 35.72 16.72 13.36 9.22 11.12 3.21%
EY 8.58 7.30 2.80 5.98 7.48 10.85 8.99 -3.06%
DY 3.31 1.11 1.12 3.90 3.37 7.10 5.00 -24.06%
P/NAPS 0.79 0.75 0.76 0.55 0.63 0.65 0.91 -9.00%
Price Multiplier on Announcement Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 30/08/21 31/05/21 26/02/21 27/11/20 28/08/20 22/05/20 28/02/20 -
Price 4.91 4.28 4.33 3.83 3.30 3.47 4.82 -
P/RPS 2.48 2.23 2.50 2.24 1.91 1.94 2.67 -4.80%
P/EPS 12.42 13.51 35.97 20.79 12.38 8.88 10.41 12.50%
EY 8.05 7.40 2.78 4.81 8.07 11.26 9.61 -11.14%
DY 3.11 1.12 1.11 3.13 3.64 7.37 5.35 -30.37%
P/NAPS 0.84 0.74 0.77 0.69 0.58 0.63 0.85 -0.78%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment